294 related articles for article (PubMed ID: 37035209)
1. Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships.
Klosowski M; Haines L; Alfino L; McMellen A; Leibowitz M; Regan D
Front Oncol; 2023; 13():1130215. PubMed ID: 37035209
[TBL] [Abstract][Full Text] [Related]
2. Clinical, Pathological, and Ethical Considerations for the Conduct of Clinical Trials in Dogs with Naturally Occurring Cancer: A Comparative Approach to Accelerate Translational Drug Development.
Regan D; Garcia K; Thamm D
ILAR J; 2018 Dec; 59(1):99-110. PubMed ID: 30668709
[TBL] [Abstract][Full Text] [Related]
3. Canine sarcomas as a surrogate for the human disease.
Gustafson DL; Duval DL; Regan DP; Thamm DH
Pharmacol Ther; 2018 Aug; 188():80-96. PubMed ID: 29378221
[TBL] [Abstract][Full Text] [Related]
4. Canine comparative oncology for translational radiation research.
Boss MK
Int J Radiat Biol; 2022; 98(3):496-505. PubMed ID: 34586958
[TBL] [Abstract][Full Text] [Related]
5. Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas.
Hernandez B; Adissu HA; Wei BR; Michael HT; Merlino G; Simpson RM
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385676
[TBL] [Abstract][Full Text] [Related]
6. Developing a translational murine-to-canine pathway for an IL-2/agonist anti-CD40 antibody cancer immunotherapy.
Proksch SF; Matthysen CP; Jardine JE; Wyatt KM; Finlay JR; Nelson DJ
Vet Comp Oncol; 2022 Sep; 20(3):602-612. PubMed ID: 35315197
[TBL] [Abstract][Full Text] [Related]
7. The use of naturally occurring cancer in domestic animals for research into human cancer: general considerations and a review of canine skeletal osteosarcoma.
Brodey RS
Yale J Biol Med; 1979; 52(4):345-61. PubMed ID: 115162
[TBL] [Abstract][Full Text] [Related]
8. Alternative lengthening of telomeres does exist in various canine sarcomas.
Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
[TBL] [Abstract][Full Text] [Related]
9. Canine as a Comparative and Translational Model for Human Mammary Tumor.
Kwon JY; Moskwa N; Kang W; Fan TM; Lee C
J Breast Cancer; 2023 Feb; 26(1):1-13. PubMed ID: 36762784
[TBL] [Abstract][Full Text] [Related]
10. Canine and murine models of osteosarcoma.
Beck J; Ren L; Huang S; Berger E; Bardales K; Mannheimer J; Mazcko C; LeBlanc A
Vet Pathol; 2022 May; 59(3):399-414. PubMed ID: 35341404
[TBL] [Abstract][Full Text] [Related]
11. A novel trauma model: naturally occurring canine trauma.
Hall KE; Sharp CR; Adams CR; Beilman G
Shock; 2014 Jan; 41(1):25-32. PubMed ID: 24089005
[TBL] [Abstract][Full Text] [Related]
12. From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision Medicine.
Rao SR; Somarelli JA; Altunel E; Selmic LE; Byrum M; Sheth MU; Cheng S; Ware KE; Kim SY; Prinz JA; Devos N; Corcoran DL; Moseley A; Soderblom E; Hsu SD; Eward WC
Front Oncol; 2020; 10():117. PubMed ID: 32117764
[TBL] [Abstract][Full Text] [Related]
13. Improved characterization and translation of NK cells for canine immunotherapy.
Razmara AM; Gingrich AA; Toedebusch CM; Rebhun RB; Murphy WJ; Kent MS; Canter RJ
Front Vet Sci; 2024; 11():1336158. PubMed ID: 38379924
[TBL] [Abstract][Full Text] [Related]
14. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
15. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
Mason NJ
Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
[TBL] [Abstract][Full Text] [Related]
16. Comparative pathology of canine soft tissue sarcomas: possible models of human non-rhabdomyosarcoma soft tissue sarcomas.
Milovancev M; Hauck M; Keller C; Stranahan LW; Mansoor A; Malarkey DE
J Comp Pathol; 2015 Jan; 152(1):22-7. PubMed ID: 25435513
[TBL] [Abstract][Full Text] [Related]
17. Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans.
Oh W; Kim AMJ; Dhawan D; Kirkham PM; Ostafe R; Franco J; Aryal UK; Carnahan RH; Patsekin V; Robinson JP; Knapp DW; Lim SO
Cancer Res Commun; 2023 May; 3(5):860-873. PubMed ID: 37377896
[TBL] [Abstract][Full Text] [Related]
18. Genomics and transcriptomics in veterinary oncology.
Harrison BM; Loukopoulos P
Oncol Lett; 2021 Apr; 21(4):336. PubMed ID: 33692868
[TBL] [Abstract][Full Text] [Related]
19. Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers: Radiation Oncology.
Nolan MW; Kent MS; Boss MK
Front Oncol; 2019; 9():1291. PubMed ID: 31824863
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.
Canter RJ; Grossenbacher SK; Foltz JA; Sturgill IR; Park JS; Luna JI; Kent MS; Culp WTN; Chen M; Modiano JF; Monjazeb AM; Lee DA; Murphy WJ
J Immunother Cancer; 2017 Dec; 5(1):98. PubMed ID: 29254507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
